Prolonging Support After Brain Death: When Families Ask for More
Recommended Citation
Lewis A, Varelas P, and Greer D. Prolonging support after brain death: When families ask for more. Neurocrit Care 2016; 24(3):481-487.
Document Type
Article
Publication Date
6-1-2016
Publication Title
Neurocrit Care
Abstract
BACKGROUND: The manner in which brain death protocols in the United States address family objection to death by neurologic criteria has not been explored.
METHODS: Institutional brain death protocols from hospitals in the United States were reviewed to identify if and how the institution addressed situations in which families object to determination of brain death or discontinuation of organ support after brain death.
RESULTS: Protocols from 331 institutions in 25 different states and the District of Columbia were reviewed. There was no mention of how to handle a family's objections in 77.9 % (258) of the protocols. Of those that allowed for accommodation, reasons to defer brain death declaration or prolong organ support after brain death declaration included: (1) religion; (2) moral objection; (3) nonspecific social reasons; or (4) awaiting arrival of family. Recommendations to handle these situations included: (1) seek counsel; (2) maintain organ support until cardiac cessation; (3) extubate against the family's wishes; (4) obtain a second opinion; or (5) transfer care of the patient to another practitioner or facility. Protocols differed on indications and length of time to continue organ support, code status while support was continued, and time of death.
CONCLUSIONS: The majority of protocols reviewed did not mention how to handle circumstances in which families object to determination of brain death or discontinuation of organ support after brain death. The creation of guidelines on management of these complex situations may be helpful to prevent distress to families and hospital staff.
Medical Subject Headings
Brain Death; Clinical Protocols; Family; Humans; Life Support Care; Practice Guidelines as Topic; United States
PubMed ID
26490777
Volume
24
Issue
3
First Page
481
Last Page
487